受强制性开放获取政策约束的文章 - Claudio Cerchione了解详情
无法在其他位置公开访问的文章：1 篇
Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 …
A Romano, NL Parrinello, C Vetro, A Chiarenza, C Cerchione, M Ippolito, ...
Annals of hematology 97, 1009-1018, 2018
强制性开放获取政策： Government of Italy
可在其他位置公开访问的文章：14 篇
A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2
S Nolan, M Vignali, M Klinger, JN Dines, IM Kaplan, E Svejnoha, T Craft, ...
Research square, 2020
强制性开放获取政策： US National Institutes of Health, US Assistant Secretary for Preparedness …
The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents
A Romano, N Laura Parrinello, C Cerchione, M Letizia Consoli, M Parisi, ...
Blood Cancer Journal 7 (12), 649, 2017
强制性开放获取政策： Government of Italy
AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia
E Todisco, C Papayannidis, N Fracchiolla, E Petracci, C Zingaretti, ...
Cancer 129 (7), 992-1004, 2023
强制性开放获取政策： Government of Italy
Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells
A Ghelli Luserna Di Rorà, M Ghetti, L Ledda, A Ferrari, M Bocconcelli, ...
Cell Biology and Toxicology, 1-17, 2021
强制性开放获取政策： AIRC Foundation for Cancer Research in Italy
Chimeric antigen receptor T-cell therapy: what we expect soon
M Martino, V Naso, B Loteta, FA Canale, M Pugliese, C Alati, G Musuraca, ...
International Journal of Molecular Sciences 23 (21), 13332, 2022
强制性开放获取政策： Government of Italy
Gene expression profiling in multiple myeloma: redefining the paradigm of risk-adapted treatment
C Cerchione, SZ Usmani, AK Stewart, M Kaiser, L Rasche, M Kortüm, ...
Frontiers in Oncology 12, 820768, 2022
强制性开放获取政策： US National Institutes of Health
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 …
A Bruzzese, D Derudas, M Galli, EA Martino, S Rocco, C Conticello, ...
Hematological Oncology 40 (4), 704-715, 2022
强制性开放获取政策： Government of Italy
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled …
M Gentile, E Vigna, S Palmieri, M Galli, D Derudas, R Mina, R Della Pepa, ...
Haematologica 109 (1), 245, 2023
强制性开放获取政策： Government of Italy
Network meta‐analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant
C Botta, E Gigliotta, B Paiva, R Anselmo, M Santoro, PR Otero, M Carlisi, ...
Hematological Oncology 40 (5), 987-998, 2022
强制性开放获取政策： AIRC Foundation for Cancer Research in Italy
Partnering with all patients: ensuring shared decision making and evidence-based management for underrepresented groups with multiple myeloma
C Cerchione, SJ Grant, S Ailawadhi
American Society of Clinical Oncology Educational Book 43, e390202, 2023
强制性开放获取政策： US National Institutes of Health
Tamoxifen protects breast cancer patients from COVID-19: first evidence from real world data
S Bravaccini, F Nicolini, W Balzi, I Azzali, A Calistri, C Parolin, A Vitiello, ...
强制性开放获取政策： European Commission
The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic
FA Canale, M Martino, G Porto, C Verduci, G Console, G Irrera, B Loteta, ...
Supportive Care in Cancer 31 (6), 350, 2023
强制性开放获取政策： Government of Italy
126. Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection and Vaccination
TM Snyder, RM Gittelman, M Klinger, DH May, EJ Osborne, R Taniguchi, ...
Open Forum Infectious Diseases 8 (Supplement_1), S77-S77, 2021
强制性开放获取政策： US National Institutes of Health
Why the complications of COVID-19 patients differ in elderly and young cancer patients
S Bravaccini, F Nicolini, M Zanoni, A Gaimari, C Cerchione, R Maltoni, ...
Translational Oncology 26, 101541, 2022
强制性开放获取政策： Government of Italy
出版信息和资助信息由计算机程序自动确定